0.438 and r=0.670) (p<0.05).The % change of LpPLA2 was related to respective change of CircS (r=0.430) and of HDL-LpPLA2 and HDL-LpPLA2/LpPLA2 with the respective change of CFR (r=0.478 and r=0.430) (p<0.05 for all associations). Conclusion: HDL-LpPLA2 is related with oxidative stress, abnormal LV deformation and CFR.IL-1 inhibition causes a secondary decrease in HDL-LpPLA2 activity probably through reduction an excessively high nitrooxidative stress
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Bone morphogenetic protein receptor activation plays a crucial role in endothelial dysfunction and osteogenic differentiation in mice with chronic kidney disease Background: Endothelial dysfunction and vascular calcification are the major cardiovascular complications in patients with chronic kidney disease (CKD). Recently, we showed that endothelial dysfunction is caused by reduced endothelial nitric oxide synthase (eNOS) phosphorylation at Ser1177 in CKD mice. However, little is known regarding the mechanisms of reduction of eNOS phosphorylation in CKD. Bone morphogenetic protein (BMP) receptor signaling is a key pathway of bone metabolism through Smad1/5/8 phosphorylation. The aim of this study was to examine the role of BMP receptor signaling in endothelial dysfunction and vascular osteogenic differentiation in CKD.
Methods and results:
We created a CKD model by performing 5/6 nephrectomy in wild-type (WT) mice, which increased serum creatinine levels 2-fold without changing blood pressure. WT mice with CKD (WT+CKD) showed impaired endothelium-dependent relaxation and reduced eNOS and Akt phosphorylations in the aorta. Immunohistostaining revealed that phosphorylated Smad1/5/8 was increased in the endothelial cells and medial vascular smooth muscle cells (VSMCs) of the aorta in WT+CKD mice. To investigate the causal relationship between BMP receptor activation and endothelial dysfunction, CKD was created in mice with heterozygous ablation of Alk3 (Alk3+/-), a BMP type 1 receptor. Basal and CKD-induced increases in serum creatinine levels were similar between WT and Alk3+/-mice. CKD-induced deterioration of endothelium-dependent relaxation and reduction of eNOS were abolished in Alk3+/-mice. In addition, alkaline phosphatase activity was increased in medial VSMCs of WT+CKD mice, but not in those of Alk3+/-+CKD mice. Conclusions: BMP receptor activation plays a crucial role in CKD-induced endothelial dysfunction and VSMC osteogenic differentiation. Thus, inhibition of BMP receptor signaling may be a therapeutic target for the prevention and treatment of endothelial dysfunction and vascular calcification in CKD patients.
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Increased plasma Glucagon Like Peptide-1 improves endothelial dysfunction immediately after Roux-en-Y gastric bypass prior to body weight loss inhibiting the c-Jun N-terminal Protein Kinase Signaling Purpose: Roux-en-Y Gastric Bypass (RYGB) reduces weight and cardiovascular risk in obese patients. The mechanism of RYGB cardiovascular protection (CV) seems to be partly weight-independent, but still unclear. Glucagon Like Peptide 1 (GLP-1) exerts endothelial protective actions, through endothelial-NO-Synthase (eNOS) activation. Thus, we investigated the role of GLP-1 in obesity-induced endothelial dysfunction in rats after RYBG, prior to significant weight loss. Methods: After 7 weeks of high fat-high-cholesterol diet, obese Wistar male rats underwent RYGB and were compared to sham-operated rats fed Ad Lib (AL) or body weight-matched (BWM) to rats receiving RYGB. Thoracic aortic rings were suspended for isometric tension recording; cumulative relaxation responses were performed to peptide GLP-1 (7-36) amide (10-12-10-6mol/L) after submaximal contraction with norepinephrine (10-6mol/L) and repeated after preincubation with GLP-1 receptor antagonist exendin (9-39) (10-7 mol/L) and eNOS-inhibitor (L-NAME, 10-4mol/L). Western blotting of aortic lysates using GLP-1 receptor (GLP1r), eNOS, Protein Kinase A (PKA) and c-Jun N-terminal Protein Kinase (JNK) antibodies was performed to address the role of GLP-1 signaling in endothelial function. GLP-1 and bile acids plasma fasting levels were measured. Results: 8 days post-surgery body weight difference among the 3 groups was not yet significant. GLP-1-induced vasorelaxation was impaired in sham AL and BWM compared with RYGB rats (max relaxations: 17±3.1% and 15±2.8 vs 36±4.8, respectively, n=6-8, p<0.05). Exendin (9-36) and L-NAME inhibited GLP-1-induced vasodilation, suggesting GLP-1 receptor and eNOS activation. Interestingly, GLP1r protein expression was decreased in aortic lysates from sham AL and BWM compared to RYGB (respectively 0.44±0.1; 0.49±0.1 vs 0.86±0.2 relative units, p<0.05) while eNOS expression was reduced (sham AL 0.45±0.1and BWM 0.34±0.1 vs RYGB 0.74±0.1). Moreover, PKA which is downstream of GLP-1r activation and inhibits JNK signaling, was upregulated in RYGB compared to the AL and BWM sham rats. Accordingly, JNK phosphorylation was blunted only in the aortae of RYGB rats. Plasma fasting levels of GLP-1 were higher after RYGB compared to sham AL and BWM (AL 0.8±0.1; BWM 2.0±0.9; RYGB 10±2.8 pg/ml, p<0.05). Furthermore, plasma bile acids, which stimulate GLP-1 secretion from L cells in the lower intestine, were also increased in RYGB compared to both sham AL and BWM. Conclusions: Our study suggests that GLP-1 may be a crucial mediator of the endothelial function improvement observed immediately after RYGB, in addition to weight loss. Purpose: Significant sex differences exist in cardiovascular diseases. A critical impact of gonadal hormones on pathogenesis, disease progression and outcome is presumed. However, it is largely unknown whether sexually dimorphic gene expression also plays a role, and whether cells themselves show intrinsic sex differences. Methods: We performed whole genome expression analyses in Human Umbilical Vein Endothelial Cells (HUVEC) from 20 male and 20 female donors and compared levels of gene transcription between the sexes. Furthermore, to investigate whether there is a sex-specific response to stress, we subjected male and female HUVEC to laminar shear stress of 6 dyn/cm 2 for 24 hours and analyzed gene expression. Results: Genes indicative for greater immune responsiveness were stronger expressed in female compared to male HUVEC. There was a significant enrichment of 77 immune-related genes in female HUVEC. Increased transcriptional levels in female cells were verified for 20 genes by real-time RT-PCR. After shear stress, 6.7% of all mRNAs were regulated. Female HUVEC showed a much stronger pronounced transcriptional response to shear than did their male counterparts. For instance, expression of VCAM-1 was 22.2-fold downregulated in female cells compared to 3.5-fold in male cells after shear. Downregulation of endothelin-1 after shear stress was 8.9 fold in female HUVEC and 4.8 fold in male HUVEC. In addition to quantitative differences, a number of genes were regulated in the opposite direction between the two sexes by shear stress. Conclusions: Our results suggest that sexual dimorphism in endothelial cells Downloaded from https://academic.oup.com/eurheartj/article-abstract/34/suppl_1/P616/2859953 by guest on 16 January 2020
P618 | BENCH

